 , Anti-Acne Preparations , Anti-Acne Preparations for Topical Use , Anti-Bacterial Agents , Anti-Infective Agents , Antibacterials for Systemic Use , Antiinfectives for Systemic Use , Antiinfectives for Treatment of Acne , BSEP/ABCB11 Inhibitors , BSEP/ABCB11 Substrates , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (moderate) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A5 Inhibitors , Cytochrome P-450 CYP3A5 Inhibitors (moderate) , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A7 Inhibitors , Cytochrome P-450 CYP3A7 Inhibitors (moderate) , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Dermatologicals , Enzyme Inhibitors , Erythromycin and similars , Erythromycins , Gastrointestinal Agents , Lactones , Macrolide Antimicrobial , Macrolides , Macrolides, Lincosamides and Streptogramins , Moderate Risk QTc-Prolonging Agents , OATP1B1/SLCO1B1 Inhibitors , OATP1B1/SLCO1B1 Substrates , OATP1B3 inhibitors , OATP1B3 substrates , Ophthalmologicals , P-glycoprotein inhibitors , P-glycoprotein substrates , Protein Synthesis Inhibitors , QTc Prolonging Agents